JENNIFER LATIMORE: Open Payments
NPI 1942535125 · OLATHE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,286 in 179 payments from 20 companies in 2025. Trend: 2023 $1,775 · 2024 $2,913 · 2025 $3,286
Food & beverage: $3,203Education: $83
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 52 | $1,059 |
| Novartis Pharmaceuticals Corporation | 13 | $277 |
| UCB, Inc. | 13 | $276 |
| ABBVIE INC. | 17 | $236 |
| MAYNE PHARMA COMMERCIAL LLC | 10 | $201 |
| E.R. Squibb & Sons, L.L.C. | 14 | $174 |
| PFIZER INC. | 12 | $151 |
| Lilly USA, LLC | 10 | $141 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $122 |
| Arcutis Biotherapeutics, Inc. | 3 | $113 |
Products named: TREMFYA, Bimzelx, COSENTYX, SKYRIZI, Sotyktu, CIBINQO, DUPIXENT, TALTZ.
Industry payments across KS — which companies pay providers there.
